Skip to main content

Table 2 Correlation between AURKA expression level and clinical features in 49 GIST patients

From: Aurora kinase A (AURKA) promotes the progression and imatinib resistance of advanced gastrointestinal stromal tumors

Parameter

Characteristic

No. patients (%)

AURKA score

Statistics

P value

Gender

Female

23 (46.9)

1.93 ± 1.35

t = − 0.430

0.669

Male

26 (53.1)

2.12 ± 1.52

  

Age

< 57

24 (49.0)

2.05 ± 1.52

t = − 0.121

0.904

≥ 57

25 (51.0)

2.00 ± 1.36

  

Location

Stomach

14 (28.6)

1.74 ± 1.30

 F = 1.321

0.277

Small intestine

12 (24.5)

1.68 ± 1.30

  

Large intestine

23 (46.9)

2.37 ± 1.53

  

Risk*

High

18 (36.7)

2.02 ± 1.43

 F = 35.449

< 0.001

Intermediate

4 (8.2)

2.1 ± 1.29

  

Low

20 (40.8)

1.26 ± 0.74

  

Very low

7 (14.3)

0.40 ± 0.52

  
  1. *P < 0.05 was considered statistically significant